• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

16.50 +0.54 (+3.38%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,945,724
Open 16.00
Bid (Size) 15.58 (100)
Ask (Size) 17.49 (100)
Prev. Close 15.96
Today's Range 15.55 - 17.24
52wk Range 3.970 - 19.00
Shares Outstanding 92,400,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
January 16, 2026
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.8% in the afternoon session after Evercore ISI upgraded the stock to Outperform from In Line and significantly raised its... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering Supply Chain
News headline image
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
January 09, 2026
From Fortrea Holdings Inc
Via GlobeNewswire

Performance

YTD
-1.8%
-1.8%
1 Month
+1.9%
+1.9%
3 Month
+74.6%
+74.6%
6 Month
+251.8%
+251.8%
1 Year
-7.4%
-7.4%

More News

Read More
News headline image
Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
January 06, 2026
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
3 Small-Cap Stocks Walking a Fine Line
January 05, 2026
Via StockStory
News headline image
3 Unpopular Stocks We Steer Clear Of
December 30, 2025
Via StockStory
News headline image
3 Inflated Stocks with Open Questions
December 28, 2025
Via StockStory
News headline image
3 Stocks Under $50 Walking a Fine Line
December 24, 2025
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Up Today
December 19, 2025
Via StockStory
Topics Initial Public Offering
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
December 18, 2025
Via StockStory
Topics Initial Public Offering
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
December 16, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
December 12, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Why Fortrea (FTRE) Stock Is Up Today
December 11, 2025
Via StockStory
Topics Artificial Intelligence Initial Public Offering
News headline image
Important Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); CarMax, Inc. (NYSE: KMX); Fortrea Holdings, Inc. (NASDAQ: FTRE); StubHub Holdings, Inc. (NYSE: STUB): Grabar Law Office Investigates Claims on Your Behalf
December 11, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
December 10, 2025
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
December 08, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
December 04, 2025
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims
December 02, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf
December 01, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Inspire Medical Systems, Inc. (NYSE: INSP); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on
November 26, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Fortrea (FTRE) Stock Trades Up, Here Is Why
November 25, 2025
Via StockStory
Topics Artificial Intelligence Government Initial Public Offering
News headline image
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
November 25, 2025
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know
November 24, 2025
Via StockStory
Topics Economy Government
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your Behalf
November 24, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
November 24, 2025
From Grabar Law Office
Via GlobeNewswire
News headline image
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
November 24, 2025
From Fortrea Holdings Inc
Via GlobeNewswire

Frequently Asked Questions

Is Fortrea Holdings Inc. - Common Stock publicly traded?
Yes, Fortrea Holdings Inc. - Common Stock is publicly traded.
What exchange does Fortrea Holdings Inc. - Common Stock trade on?
Fortrea Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fortrea Holdings Inc. - Common Stock?
The ticker symbol for Fortrea Holdings Inc. - Common Stock is FTRE on the Nasdaq Stock Market
What is the current price of Fortrea Holdings Inc. - Common Stock?
The current price of Fortrea Holdings Inc. - Common Stock is 16.50
When was Fortrea Holdings Inc. - Common Stock last traded?
The last trade of Fortrea Holdings Inc. - Common Stock was at 01/16/26 04:00 PM ET
What is the market capitalization of Fortrea Holdings Inc. - Common Stock?
The market capitalization of Fortrea Holdings Inc. - Common Stock is 1.52B
How many shares of Fortrea Holdings Inc. - Common Stock are outstanding?
Fortrea Holdings Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap